Global Market for Cancer Vaccines - Analysis, Technologies & Forecasts to 2021 - Includes Relevant Patent Analysis, By Year & Vaccine Type - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cancer Vaccines: Technologies and Global Markets" report to their offering.

The global market for cancer vaccines was valued at nearly $4.2 billion and $4.0 billion in 2014 and 2015, respectively. This market is expected to decline from nearly $3.5 billion in 2016 to $3.4 billion in 2021 at a compound annual growth rate (CAGR) of -0.4% for 2016-2021.

The report provides an overview of the global markets and technologies for cancer vaccines. It includes analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of CAGRs through 2021. It also contains coverage of the cancer vaccines arena including diverse therapeutic platform technologies, immune-stimulating agents and approved vaccines for cancer.

Scope of the Report:

  • Examination of the governmental and regulatory environment and how its effecting the market.
  • Information on new developments including products in Phase I-IV clinical trials, as well as new technologies.
  • Analysis of the market's dynamics, specifically growth and restriction factors, acquisitions and collaborations, and a look at the cancer vaccine market's current achievements and future challenges.
  • Relevant patent analysis, presented by year and by vaccine type.
  • Profiles of major players in the industry.

The report also covers the global market of cancer vaccines by application in various cancer types such as prostate, liver, cervical and others such as lung and urinary bladder. It is discussed from both a commercial perspective and that of a research and development (R&D) perspective.

Companies Mentioned

  • Celldex Therapeutics
  • Curevac AG
  • Dendreon Corp.
  • EMD Serono
  • Galena Biopharma Inc.
  • Genexine Inc.
  • Glaxosmithkline
  • Globeimmune Inc.
  • Gradalis
  • Heat Biologics Inc.
  • Immune Cell Therapy Inc. (Ict)
  • Immunicum AB
  • Immunovative Therapies Ltd.
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals B.V.
  • Gemvax & Kael Co. Ltd.
  • Merck & Co.
  • Newlink Genetics Corp.
  • Novarx Corp.
  • (10+ Others)

Key Topics Covered:

1: Introduction

2: Executive Summary

3: Overview

4: Regulatory Aspects

5: New Developments

6: Market Analysis

7: Industry Structure

8: Market By Application

9: Patent Analysis

For more information about this report visit http://www.researchandmarkets.com/research/v99t39/cancer_vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cancer Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cancer Vaccines